Squarepoint’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-180,913
| Closed | -$400K | – | 3031 |
|
2025
Q1 | $400K | Buy |
+180,913
| New | +$400K | ﹤0.01% | 2034 |
|
2024
Q4 | – | Sell |
-71,959
| Closed | -$598K | – | 3071 |
|
2024
Q3 | $598K | Sell |
71,959
-283,631
| -80% | -$2.36M | ﹤0.01% | 1662 |
|
2024
Q2 | $2.55M | Buy |
355,590
+229,421
| +182% | +$1.64M | ﹤0.01% | 960 |
|
2024
Q1 | $1.09M | Sell |
126,169
-183,851
| -59% | -$1.59M | ﹤0.01% | 1313 |
|
2023
Q4 | $2.03M | Buy |
+310,020
| New | +$2.03M | ﹤0.01% | 1021 |
|
2023
Q3 | – | Sell |
-265,700
| Closed | -$3.3M | – | 2701 |
|
2023
Q2 | $3.3M | Buy |
265,700
+98,399
| +59% | +$1.22M | 0.01% | 699 |
|
2023
Q1 | $2.34M | Buy |
167,301
+119,467
| +250% | +$1.67M | 0.01% | 774 |
|
2022
Q4 | $685K | Buy |
+47,834
| New | +$685K | ﹤0.01% | 1304 |
|
2022
Q2 | – | Sell |
-20,428
| Closed | -$720K | – | 2444 |
|
2022
Q1 | $720K | Sell |
20,428
-40,725
| -67% | -$1.44M | ﹤0.01% | 1304 |
|
2021
Q4 | $2.56M | Buy |
+61,153
| New | +$2.56M | 0.01% | 754 |
|
2021
Q3 | – | Sell |
-186,062
| Closed | -$7.76M | – | 2557 |
|
2021
Q2 | $7.76M | Buy |
186,062
+34,062
| +22% | +$1.42M | 0.03% | 348 |
|
2021
Q1 | $5.42M | Sell |
152,000
-152,479
| -50% | -$5.43M | 0.03% | 397 |
|
2020
Q4 | $8.54M | Buy |
+304,479
| New | +$8.54M | 0.06% | 253 |
|